The hepatitis B virus X gene product trans activates transcription from a variety of viral and cellular regulatory elements. We expressed the complete, nonfused X protein in Escherichia coli and showed it to be active in trans activating a human immunodeficiency virus long terminal repeat-linked chloramphenicol acetyltransferase reporter gene. Hepatitis B virus (HBV) contains an open reading frame called X, located between nucleotide positions 1376 and 1840 (in subtype adw), and encodes a protein of 154 amino acids or 16,560 daltons (9). The precise role of X protein during HBV infection is not clear. However, recent studies have established a trans-activating function for this protein (6) (7) (8) 13 ). With various cell lines, cotransfection studies using reporter gene systems have shown that the X gene product can activate transcription from the following regulatory elements: the HBV enhancer (1, 7), the simian virus 40 enhancer (8, 13), the human immunodeficiency virus (HIV) long terminal repeat (LTR) (6, 7, 10), the Rous sarcoma virus LTR (7, 13), the human T-lymphotropic virus type LTR (13), the herpes simplex virus thymidine kinase promoter (13), and the beta interferon gene promoter (11). This transactivating property has also been established in human liver cells that stably express the X gene (7), as well as by integrated X gene sequences isolated from hepatocellular carcinoma tissue (12). Deletion mutagenesis studies on the HIV LTR (7, 10) have mapped the X-responsive elements within the enhancer region containing two direct repeats of the sequence GGGACTTTCC. These sequences are target sites for a transcription factor, NF-KB (5). Sequences bearing close homology to the NF-KB binding site are also present in at least some of the other X-responsive regulatory elements.
The hepatitis B virus X gene product trans activates transcription from a variety of viral and cellular regulatory elements. We expressed the complete, nonfused X protein in Escherichia coli and showed it to be active in trans activating a human immunodeficiency virus long terminal repeat-linked chloramphenicol acetyltransferase reporter gene. Hepatitis B virus (HBV) contains an open reading frame called X, located between nucleotide positions 1376 and 1840 (in subtype adw), and encodes a protein of 154 amino acids or 16,560 daltons (9) . The precise role of X protein during HBV infection is not clear. However, recent studies have established a trans-activating function for this protein (6) (7) (8) 13) . With various cell lines, cotransfection studies using reporter gene systems have shown that the X gene product can activate transcription from the following regulatory elements: the HBV enhancer (1, 7), the simian virus 40 enhancer (8, 13) , the human immunodeficiency virus (HIV) long terminal repeat (LTR) (6, 7, 10) , the Rous sarcoma virus LTR (7, 13) , the human T-lymphotropic virus type LTR (13) , the herpes simplex virus thymidine kinase promoter (13) , and the beta interferon gene promoter (11) . This transactivating property has also been established in human liver cells that stably express the X gene (7), as well as by integrated X gene sequences isolated from hepatocellular carcinoma tissue (12) . Deletion mutagenesis studies on the HIV LTR (7, 10) have mapped the X-responsive elements within the enhancer region containing two direct repeats of the sequence GGGACTTTCC. These sequences are target sites for a transcription factor, NF-KB (5). Sequences bearing close homology to the NF-KB binding site are also present in at least some of the other X-responsive regulatory elements.
Little is known about the mechanisms of X-mediated regulation. Our interest is detailed structure-function analysis of the X protein to elucidate domains important for its activity. Two important prerequisites for this are the availability of large amounts of the active protein and an assay system to assess its functional activity. Therefore, we expressed the HBV X protein in Escherichia coli and purified it to homogeneity. Further, by using a simple cellular uptake assay, we al., in press) to yield plasmid pET-X (Fig. 1A) . This (Fig. 1B) .
To establish that the 16-to 17-kilodalton protein is in fact the HBV X protein, a Western immunoblotting experiment was performed. Polyclonal antisera against two synthetic peptides from the HBV X protein were raised in rabbits. These peptides included amino acids 100 to 114 (HBX100) or 144 to 154 (HBX144) and were coupled to keyhole limpet hemocyanin or purified protein derivative, respectively, before injection. Proteins synthesized in transformed E. coli induced with IPTG were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose. On probing with anti-HBX144, the 16-to 17-kilodalton band was seen only in pET-X transformed cells ( Fig. 2A) . Furthermore, a linear response to IPTG induction was also seen. Similar results were also obtained with anti-HBX100 (data not shown). To further establish the specificity of the anti-peptide sera, a cross-competition Western analysis was done. Nitrocellulose strips containing total E. coli lysates were incubated with either antiserum without or with the specific or the nonspecific peptide. The results (Fig. 2B) showed that a major protein band corresponding to the X protein monomer was eliminated by the specific peptide (lanes 3 and 7) but not by the nonspecific peptide (lanes 4 and 6). This showed that the expressed protein was indeed the HBV X protein. Two extra bands seen with anti-HBX100 may have been due to bacterial proteins with homology to the HBX100 peptide sequence. To purify the expressed X protein, cells from cultures induced for 3 h were suspended in 5 to 10% of the culture volume of 50 mM Tris (pH 8.5-10 mM EDTA. After one freeze-thaw cycle, the cells were disrupted by sonication and the lysate was centrifuged at 14,000 x g for 15 min. The pellet was suspended in the above-described buffer containing 30% (wt/vol) sucrose and collected by centrifugation. This pellet was dissolved in the above described buffer containing 6 M urea and 5 mM 2-mercaptoethanol. At 8.6 (fractions 12 to 14); the peak fraction (no. 13) had a pH of 8.3 , which is close to the theoretical pl of 8. 5 . This gave electrophoretically pure X protein (Fig. 3) .
The only known function of X protein is to trans activate .27
certain cis-acting regulatory elements. Of these, the HIV LTR is the best characterized. We used a HeLa cell-derived line (LTR3CAT) stably transfected with a plasmid contain-17 ing the bacterial gene for chloramphenicol acetyltransferase (CAT) under control of the HIV LTR sequences. The assay systems used were those described earlier-direct cellular uptake of proteins (4) or scrape loading of cells with proteins (2). Figure 4 shows the results of expression of the gene for CAT in the LTR3CAT cell line. Whereas very low background CAT activity was seen in the cells (lanes 1 and 2),
FIG. 2. Western analysis of X protein expression. (A)
Control and pET-X-transformed E. coli cells were induced, and proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis as described in the legend to Fig. 1B . The filter with transferred protein was blocked with 1% nonfat milk in phosphatebuffered saline for 2 h followed by successive incubations with a 1:100 dilution of anti-HBX144 (in phosphate-buffered saline-milk) and a 1:500 dilution of horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (in phosphate-buffered saline) for 2 to 3 h each. The blot was then developed by using 4-chloronaphthol as the substrate. MW, Molecular weight. (B) Nitrocellulose strips containing total proteins from pET-X-transformed E. coli were incubated with preimmune sera (1:100), anti-HBX100 (1:100), or anti-HBX144 (1:250). For competitions, peptide HBX100 or HBX144 was also included in the primary antibody incubation at a concentration of 0.5 mg/ml. The secondary antibody and color development were as described above. Bands eliminated by specific peptides (*) and the position of the X protein monomer (arrow) are indicated. there was an approximately eightfold increase on scrape loading of the X protein into these cells (lanes 3 and 4) . The increase was even more pronounced, up to 30-fold, when the cells were simply overlaid with protein (lanes 5 and 6). This level of stimulation by X is consistent with the results obtained by others following DNA transfection (7) . This trans activation appeared to be specific, as there was no increase in the levels of actin RNA when X protein-containing extract was loaded into LTR3CAT cells compared with control extracts (data not shown). Thus, the X protein produced in E. Partially purified protein extracts were prepared from E. coli transformed with plasmid pET-X (X extract) or pET-8C (control extract); the protein content of the former was equivalent to that shown in Fig. 1 and 2 . This preparation, at a total protein concentration of 100 jig/ml, was added to 2 ml of Dulbecco modified Eagle medium containing 10% fetal bovine serum and overlaid on a monolayer of LTR3CAT cells. For scrape loading, the cells were gently scraped off the plate in the above-described medium and then allowed to settle down. After 6 h at 37°C, 8 ml of fresh Dulbecco modified Eagle medium with 10% fetal bovine serum was added and the cells were harvested for CAT assay (3) LTR, the NF-KB factor may be one such transcription factor influenced by X. It is known that under noninducing conditions or in nonlymphocytic cells, NF-KB is found in the cytoplasm, bound to an inhibitor (IKB) (5). HBV X protein may act, for example, by shifting the equilibrium in favor of free NF-KB. Availability of pure preparations of X protein will facilitate inquiry into its ability to interact with other proteins. More detailed analysis remains to be performed in terms of the domains of X protein essential for trans activation. Establishment of the good expression and assay systems reported here forms the basis for future studies.
